Sanofi to acquire Synthorx for $2.5 billion
December 09, 2019 at 02:09 AM EST
The French pharmaceutical company said it plans to take control of all outstanding shares of Synthorx for $68 per share in cash.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|